-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- Reviva Pharmaceuticals Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $7.4 K, a 148% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $21.4 K, a 6.17% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $16.9 K, a 18.4% decline from 2022.
- Reviva Pharmaceuticals Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $20.8 K, a 246% increase from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $6 K, a 651% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)